During the COVID-19 public health emergency, federal PREP Act declarations temporarily expanded which vaccines pharmacists could administer, to which age groups, and under what supervision — often overriding narrower state-law limits for the duration of the declaration. That federal overlay has wound down, and pharmacist vaccine authority in 2026 is largely back to being governed by each state’s own statute and board rules. This is a look at where that authority currently stands — not guidance on administering any specific vaccine.
What the PREP Act expansions actually did
The relevant PREP Act declarations authorized pharmacists (and, in many cases, supervised pharmacy interns and technicians) to order and administer FDA-authorized or approved vaccines to patients, including age groups and vaccine types that some state laws didn’t otherwise cover. The federal authorization operated as a liability shield and scope override tied specifically to the public health emergency declarations — it was never a permanent change to state pharmacy practice acts.
As those declarations have expired or been narrowed, pharmacist vaccine authority has reverted, state by state, to whatever each state’s own immunization statute independently provides. That reversion hasn’t been uniform, which is the main source of confusion right now.
Where state authority landed after the federal expansion wound down
Roughly, states have landed in one of two places:
States that codified broader authority into permanent law. A number of states used the pandemic-era experience as the basis for legislation permanently expanding pharmacist vaccine authority — lowering minimum age limits for certain vaccines, adding vaccine types to the authorized list, or extending order/administer authority to pharmacy interns under supervision on a standing basis rather than an emergency one. Where this happened, current authority may be broader than pre-2020 law even though the federal emergency authority has ended.
States where authority reverted to pre-pandemic scope. In states that didn’t pass new legislation, pharmacist vaccine authority has generally reverted to whatever the state’s immunization statute said before the PREP Act declarations — which in some states means narrower age ranges, a shorter list of authorized vaccines, or supervision requirements for technicians and interns that had been temporarily relaxed.
Because these are two genuinely different outcomes reached independently by each state legislature and board, there’s no way to infer current authority in a given state from what was true during the emergency period, or from what’s true in a neighboring state.
What still tends to vary by state regardless of pandemic-era changes
Independent of the PREP Act history, several dimensions of vaccine authority have always been state-specific and remain so:
- Minimum patient age a pharmacist can vaccinate without a prescriber order
- Which vaccines are covered by standing order versus which require a patient-specific prescription
- Whether pharmacy interns and technicians can administer vaccines under supervision, and what training that requires
- Reporting obligations to state immunization registries
- Required certification (such as an APhA-style immunization training program) as a prerequisite to vaccine authority
Our broader immunization authority by state piece covers this state-by-state framework in more detail, and the pharmacist immunization certification requirements post covers the training prerequisites separately from the authority question itself.
Standing orders and ACIP schedule changes
Vaccine authority frameworks in most states are tied to ACIP’s recommended immunization schedule — a pharmacist’s standing-order authority typically references “vaccines recommended by ACIP” rather than a fixed drug list, which means the practical scope of what a pharmacist can administer shifts automatically as ACIP updates its recommendations, without requiring new state legislation. This is a different mechanism than the PREP Act expansions, and it’s worth not conflating the two when trying to determine current authority.
Why this matters for pharmacists practicing in multiple states
A pharmacist licensed in more than one state may have meaningfully different vaccine administration authority in each one, particularly if one state codified pandemic-era expansions and another reverted. This is the kind of scope difference that’s easy to miss because it doesn’t show up as a licensing requirement — it’s a scope-of-practice question layered on top of an active license, similar to the variation covered in our piece on pharmacist naloxone training programs.
Confirm current authority before relying on this overview
Vaccine administration authority is one of the more frequently updated areas of pharmacy scope of practice, and the post-PREP Act landscape described here is a general framework, not a state-specific answer. Confirm current vaccine authority — including age limits, authorized vaccine lists, and certification requirements — directly with your state board of pharmacy before relying on it, and don’t treat pandemic-era guidance as still in effect without checking whether it was made permanent.
RxByState tracks pharmacist scope-of-practice changes, including vaccine administration authority, across all 50 states as boards update their rules. See current authority in your state →